Broad HIV-1 inhibition in vitro by vaccine-elicited CD8(+) T cells in African adults

We are developing a pan-clade HIV-1 T-cell vaccine HIVconsv, which could complement Env vaccines for prophylaxis and be a key to HIV cure. Our strategy focuses vaccine-elicited effector T-cells on functionally and structurally conserved regions (not full-length proteins and not only epitopes) of the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Ther Methods Clin Dev
Autors principals: Mutua, Gaudensia, Farah, Bashir, Langat, Robert, Indangasi, Jackton, Ogola, Simon, Onsembe, Brian, Kopycinski, Jakub T, Hayes, Peter, Borthwick, Nicola J, Ashraf, Ambreen, Dally, Len, Barin, Burc, Tillander, Annika, Gilmour, Jill, De Bont, Jan, Crook, Alison, Hannaman, Drew, Cox, Josephine H, Anzala, Omu, Fast, Patricia E, Reilly, Marie, Chinyenze, Kundai, Jaoko, Walter, Hanke, Tomáš, HIV-CORE 004 study group, the
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5006719/
https://ncbi.nlm.nih.gov/pubmed/27617268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mtm.2016.61
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars